ArticleEuropean journal of nuclear medicine and molecular imaging2018
Simultaneous whole-body
Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03537391 (Imaging for Prostate Cancer Metastasis Detection - Traditional Imaging), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Imaging for Prostate Cancer Metastasis Detection - Traditional Imaging (Bone Scan and CT) Versus PSMA-PET-CT, SPECT-CT and Whole-Body MRI
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- PET/MRI in prostate cancer: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021Pooled it
- Fully Automated Production of (((Pharmaceuticals (Basel, Switzerland) · 2025Article
- Enhancing the diagnostic capacity of [EJNMMI reports · 2024Article
- Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen.Current oncology (Toronto, Ont.) · 2024Review
- Status ofWorld journal of urology · 2023Article
- Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CTThe British journal of radiology · 2022Review
- Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology.Prostate cancer and prostatic diseases · 2021Article
- A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer.Translational andrology and urology · 2020Review
- Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer.Japanese journal of clinical oncology · 2020Review
- Clinical Utility ofFrontiers in oncology · 2020Article
- Clinical perspectives of PSMA PET/MRI for prostate cancer.Clinics (Sao Paulo, Brazil) · 2018Review
- Highlights of the 30th Annual Congress of the EANM, Vienna 2017: "Yes we can - make nuclear medicine great again".European journal of nuclear medicine and molecular imaging · 2018Review
- The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer.Asian journal of andrologyArticle
- Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges.Korean journal of radiologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of the present study was to explore the clinical feasibility and reproducibility of a comprehensive whole-body
methodsEight patients with high-risk biopsy-proven PC underwent a whole-body PET/MRI (3 h p.i.) including a multi-parametric prostate MRI after
resultsThe examinations were well accepted by patients and comprised 1 h. SUV
conclusionsThe presented
Indexed as
Identifiers
29038888What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.